Press release
Calliope Health Publishes Transparent Pricing for Ketamine and Spravato Treatment in Bethesda
As cost remains one of the most common questions for patients considering ketamine or Spravato treatment, the Bethesda psychiatric clinic lays out its full self-pay and insurance pricingBETHESDA, MD - August 26, 2026 - Calliope Health [https://calliope.health/], a psychiatric clinic based in Bethesda, Maryland offering Spravato (esketamine) and ketamine-assisted treatment for depression, anxiety, and PTSD, is publishing a clear breakdown of what treatment costs, a question the clinic says comes up in nearly every first conversation with a prospective patient.
Why Cost Is Often the First Question
Ketamine and Spravato are still relatively new treatment options for many patients, and pricing across providers varies widely and isn't always published clearly. For a treatment patients are often considering only after other options haven't worked, unclear pricing can become one more barrier at an already difficult moment. Calliope Health publishes its full self-pay fee schedule for that reason, so patients can evaluate treatment as a real financial decision before their first appointment rather than after.
What Treatment Costs at Calliope Health
According to the clinic's published self-pay fee schedule [https://calliope.health/pricing/], an IV ketamine assessment is $250, and each IV ketamine infusion is $325. A 45-minute psychotherapy or integration session runs $275, a self-pay psychiatric evaluation is $250, and a 30-minute medication management follow-up is $200. Patients typically begin with an assessment, then move into a series of weekly ketamine sessions before transitioning to a maintenance schedule as symptoms improve.
Insurance Can Offset Much of the Cost
Spravato and its accompanying psychiatric evaluation are typically covered by insurance; Calliope Health is in-network with Aetna, Cigna, United Healthcare (Optum), and CareFirst for both. IV ketamine infusions and psychotherapy sessions aren't covered by insurance and are billed as self-pay, but the clinic provides a superbill patients can submit to their insurer for possible out-of-network reimbursement. Full details are outlined on the clinic's insurance coverage page [https://calliope.health/insurance/], and the clinic offers a complimentary insurance benefits check before treatment starts.
Financial Assistance Options
For patients who qualify, Calliope Health points to additional resources for managing the cost of treatment, including the Serenity Foundation, an organization that provides financial assistance to help patients access ketamine treatment who might not otherwise be able to afford it. Veterans and first responders may also have access to specialized financial support for ketamine treatment through organizations focused on those communities. The clinic recommends patients discuss the full cost of a treatment course with their care team, and with family or trusted advisors, before committing to a full series.
Treatment Options
The clinic offers Spravato (esketamine) nasal spray for treatment-resistant depression, IV ketamine infusions, and ketamine-assisted psychotherapy, treating anxiety, PTSD, and depression. Eligible Spravato patients can enroll in a program designed to reduce or eliminate their co-pay.
Frequently Asked Questions
Why isn't ketamine covered by insurance, if Spravato is?
Spravato (esketamine) is FDA-approved specifically for treatment-resistant depression, which is why many insurers cover it. IV ketamine is used off-label for psychiatric treatment, meaning it's approved by the FDA for other uses but prescribed for depression based on clinical evidence rather than a specific psychiatric approval, which is generally why insurers don't cover it directly.
Is a superbill the same as insurance coverage?
No. A superbill is an itemized receipt patients can submit to their own insurance company for possible partial reimbursement, but it doesn't guarantee payment and isn't the same as being in-network. Reimbursement amounts depend entirely on each patient's individual plan.
How many sessions does a typical course of treatment involve?
Most patients begin with a series of weekly ketamine sessions, then move to a maintenance schedule as symptoms improve. The total number of sessions varies by patient and is reassessed as treatment continues, since ketamine doesn't affect everyone on the same timeline.
Does the assessment fee apply toward treatment if I move forward?
The assessment is a separate, one-time evaluation to confirm a patient is a fit for treatment before scheduling begins. Patients should confirm current fee structure directly with the clinic, since self-pay pricing can be updated.
Is financial assistance available for patients who can't afford treatment?
Calliope Health points qualifying patients toward outside resources, including the Serenity Foundation, which provides financial assistance for ketamine treatment, along with specialized support programs for veterans and first responders. Availability and eligibility are determined by those organizations directly, not by the clinic.
Where is Calliope Health located?
Calliope Health is based in Bethesda, Maryland, and serves patients throughout Rockville, Silver Spring, Washington, D.C., and communities across Montgomery County, Maryland.
About Calliope Health
Founded in 2023 by psychotherapist Keith Miller, Calliope Health is a Bethesda, Maryland clinic offering Spravato (esketamine), IV ketamine infusions, and ketamine-assisted psychotherapy for depression, anxiety, and PTSD. The clinic's mission is to pair FDA-approved and evidence-based treatments with structured psychotherapy support, rather than treating medication alone as the treatment, so patients get real clinical care alongside every session. Calliope Health serves patients throughout Bethesda, Rockville, Silver Spring, Washington, D.C., and Montgomery County, Maryland, with insurance coverage available for Spravato treatment [https://www.google.com/search?Spravato+treatment&kgmid=/g/11twv42yh5]. Learn more at calliope.health.
Media Contact
Company Name: Calliope Health Ketamine
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=calliope-health-publishes-transparent-pricing-for-ketamine-and-spravato-treatment-in-bethesda]
Phone: (301) 828-9513
Address:4300 Montgomery Ave # 302
City: Bethesda
State: MD
Country: United States
Website: https://calliope.health/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Calliope Health Publishes Transparent Pricing for Ketamine and Spravato Treatment in Bethesda here
News-ID: 4614516 • Views: …
More Releases from ABNewswire
South Korea Construction Market to Reach USD 220.75 Billion by 2031 as Infrastru …
Mordor Intelligence has published a new report on the South Korea Construction Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Hyderabad, August 26, 2026: According to Mordor Intelligence the South Korea Construction Market [https://www.mordorintelligence.com/industry-reports/south-korea-construction-market?utm_source=abnewswire] was valued at USD 179.41 billion in 2025 and is estimated to grow from USD 185.77 billion in 2026 to reach USD 220.75 billion by 2031, registering a CAGR of 3.51% during the…
North America Prefabricated Buildings Market to Reach USD 72.46 Billion by 2031 …
Mordor Intelligence has published a new report on the North America Prefabricated Buildings Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Hyderabad, August 26, 2026: According to Mordor Intelligence, the North America Prefabricated Buildings Market [https://www.mordorintelligence.com/industry-reports/north-america-prefabricated-buildings-market?utm_source=abnewswire] was valued at USD 49.3 billion in 2025 and is estimated to grow from USD 52.56 billion in 2026 to USD 72.46 billion by 2031, registering a CAGR of 6.62% during…
Europe Online Travel Market to Reach USD 171.26 Billion by 2031, Driven by Mobil …
Mordor Intelligence has published a new report on the Europe Online Travel Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Hyderabad, August 26, 2026: According to Mordor Intelligence, the Europe Online Travel Market [https://www.mordorintelligence.com/industry-reports/online-travel-market-in-europe?utm_source=abnewswire] was valued at USD 103.78 billion in 2025 and is estimated to grow from USD 112.81 billion in 2026 to reach USD 171.26 billion by 2031, registering a CAGR of 8.71% during the…
Blinds Market to Reach USD 9.47 Billion by 2031 as Motorized Solutions, Smart In …
Mordor Intelligence has published a new report on the Blinds Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Hyderabad, August 26, 2026: According to Mordor Intelligence, the global blinds market [https://www.mordorintelligence.com/industry-reports/global-blinds-market?utm_source=abnewswire] was valued at USD 7.01 billion in 2025 and is estimated to grow from USD 7.37 billion in 2026 to reach USD 9.47 billion by 2031, registering a CAGR of 5.14% during the forecast period from…
More Releases for Health
Health Coach Market Positioned for Accelerated Growth with Iora Health, Virta He …
Global health coach market is estimated to be valued at USD 18.83 Bn in 2025 and is expected to reach USD 30.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.
Latest Report on the Health Coach Market 2025-2032, focuses on a comprehensive analysis of the current and future prospects of the Health Coach Market industry. An in-depth analysis of historical trends, future trends,…
Digital Musculoskeletal (MSK) Care Market Top Companies Study - Hinge Health, Sw …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Musculoskeletal (MSK) Care Market Size, Share & Trends Analysis Report Solution (Online/Virtual Consultations, Pain Management Therapy Programs, Remote Monitoring, Others), Condition (Back Pain, Foot & Ankle Pain, Knee & Lower Leg Pain, Neck & Shoulder Pain, Pelvis, Hip & Thigh Pain, Others), End User (Healthcare Providers, Healthcare Payers, Employers, Individuals/Patients, Others)- Market Outlook And…
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, …
ReportsWeb.com has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification.
This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market,…
Digital Therapeutics Market Outlook to 2025 - Propeller Health, CANARY HEALTH, N …
The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C.
Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and…
Digital Therapeutics Market Analysis 2018 | Growth by Top Companies: Proteus Dig …
Global Digital Therapeutics Market to 2025
This report "Digital Therapeutics Market Analysis to 2025" provides an in-depth insight of medical device industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis.
Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and…
Digital Therapeutics Market 2018 Global Key Player Analysis - Omada Health, Twin …
New Intelligence Report on “Digital Therapeutics Market to 2025” is recently published by The Insight Partners. The report aims to provide leading industry players with information such as company profiles, products and services offered, financial information of last 3 yesars, key development in past five years
North America is estimated to contribute to the largest share in the digital therapeutics market in the coming years, owing to factors such as, improved…
